Stay updated with breaking news from Andreaf Wainer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abbott Laboratories (NYSE:ABT – Free Report) had its price objective lifted by Citigroup from $126.00 to $128.00 in a research report sent to investors on Wednesday, Benzinga reports. They currently have a buy rating on the healthcare product maker’s stock. A number of other research analysts also recently issued reports on ABT. Wells Fargo & […]
UMB Bank n.a. reduced its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 0.3% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 274,008 shares of the healthcare product maker’s stock after selling 704 shares during the quarter. UMB Bank n.a.’s holdings in Abbott […]
UMB Bank n.a. reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 0.3% during the 4th quarter, Holdings Channel reports. The fund owned 274,008 shares of the healthcare product maker’s stock after selling 704 shares during the quarter. UMB Bank n.a.’s holdings in Abbott Laboratories were worth $30,160,000 as of its most recent […]
Cahaba Wealth Management Inc. decreased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,025 shares of the healthcare product maker’s stock after selling 195 shares during the period. Cahaba Wealth […]
Hartford Investment Management Co. cut its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 116,879 shares of the healthcare product maker’s stock after selling 2,094 shares during the quarter. Hartford […]